ALS Limited (ASX:ALQ)

Australia · Delayed Price · Currency is AUD

21.37

+0.31 (1.47%)

Sep 18, 2026, 4:11 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Commodities	1.29B	1.09B	1.09B	1.09B	886.50M
Life Sciences	2.03B	1.91B	1.38B	-	-
Life Sciences Excl Nuvisan	-	-	-	1.19B	1.07B
Elimination Nuvisan	-	-	-	-142.00M	-73.80M
Life Sciences - Nuvisan	-	-	-	142.00M	73.80M
Total	3.32B	3.00B	2.46B	2.28B	1.95B

Revenue by Geography

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Africa	74.80M	65.50M	57.60M	54.50M	45.50M
Asia/Pacific	949.90M	854.10M	810.10M	764.60M	647.20M
EMENA (Europe, Middle East, North Africa)	1.17B	1.05B	594.10M	514.50M	478.90M
Americas	1.13B	1.03B	999.80M	945.70M	780.30M
Total	3.32B	3.00B	2.46B	2.28B	1.95B